Oleamide activates peroxisome proliferator-activated receptor gamma (PPAR) in vitro

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Dionisi, Mauro ^a,b   Alexander, Stephen Ph ^a   Bennett, Andrew J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

Endocannabinoids; Oleamide; Peroxisome proliferator; PPAR

Indexed keywords

LUCIFERASE; OLEAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RECOMBINANT PROTEIN;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; BINDING COMPETITION; CELL ASSAY; CELL DIFFERENTIATION; CELL STRAIN 3T3; CHO CELL; CONTROLLED STUDY; DRUG BINDING; DRUG TARGETING; FIBROBLAST; FLUORESCENCE ANALYSIS; IC 50; IN VITRO STUDY; LIGAND BINDING; NONHUMAN; PROTEIN EXPRESSION; REPORTER GENE;

3T3-L1 CELLS; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CHO CELLS; CRICETINAE; MICE; OLEIC ACIDS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PPAR GAMMA; TRANS-ACTIVATORS;

CRICETINAE; CRICETULUS GRISEUS; MURINAE;

EID: 84860808303     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-51     Document Type: Article

References (27)

1. Chemical characterization of a family of brain lipids that induce sleep. Cravatt BF, Prospero-Garcia O, Siuzdak G, Gilula NB, Henriksen SJ, Boger DL, Lerner RA, Science 1995 268 1506 1509 10.1126/science.7770779 7770779
2. Structure and function of fatty acid amide hydrolase. McKinney MK, Cravatt BF, Annu Rev Biochem 2005 74 411 432 10.1146/annurev.biochem.74.082803. 133450 15952893 (Pubitemid 40995513)
3. Oleamide synthesizing activity from rat kidney-Identification as cytochrome C. Driscoll WJ, Chaturvedi S, Mueller GP, J Biol Chem 2007 282 22353 22363 10.1074/jbc.M610070200 17496328 (Pubitemid 47267327)
4. A spectrophotometric assay for fatty acid amide hydrolase suitable for high throughput screening. De Bank PA, Kendall DA, Alexander SPH, Biochem Pharmacol 2005 69 1187 1193 10.1016/j.bcp.2005.01.012 15794939 (Pubitemid 40417490)
5. A second fatty acid amide hydrolase with variable distribution among placental mammals. Wei BQ, Mikkelsen TS, McKinney MK, Lander ES, Cravatt BF, J Biol Chem 2006 281 36569 36578 10.1074/jbc.M606646200 17015445 (Pubitemid 46049797)
6. Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats. Herrera-Solis A, Vasquez KG, Prospero-Garcia O, Pharmacol Biochem Behav 2010 95 106 112 10.1016/j.pbb.2009.12.014 20056119
7. Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems. Fedorova I, Hashimoto A, Fecik RA, Hedrick MP, Hanus LO, Boger DL, Rice KC, Basile AS, J Pharmacol Exp Ther 2001 299 332 342 11561096 (Pubitemid 32905151)
8. Chemical synthesis of 9(Z)-octadecenamide and its hypolipidemic effect: a bioactive agent found in the essential oil of mountain celery seeds. Cheng MC, Ker YB, Yu TH, Lin LY, Peng RY, Peng CH, J Agric Food Chem 2010 58 1502 1508 10.1021/jf903573g 20078072
9. Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor. Hoi PM, Hiley CR, Br J Pharmacol 2006 147 560 568 10.1038/sj.bjp.0706643 16415907 (Pubitemid 43355054)
10. Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide. Boger DL, Patterson JE, Guan XJ, Cravatt BF, Lerner RA, Gilula NB, Proc Natl Acad Sci U S A 1998 95 4810 4815 10.1073/pnas.95.9.4810 9560184 (Pubitemid 28208507)
11. Oleamide potentiates benzodiazepine-sensitive gamma-aminobutyric acid receptor activity but does not alter minimum alveolar anesthetic concentration. Yost CS, Hampson AJ, Leonoudakis D, Koblin DD, Bornheim LM, Gray AT, Anesth Analg 1998 86 1294 1300 9620523 (Pubitemid 28249255)
12. Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide. Thomas EA, Carson MJ, Neal MJ, Sutcliffe JG, Proc Natl Acad Sci U S A 1997 94 14115 14119 10.1073/pnas.94.25.14115 9391162 (Pubitemid 28009719)
13. Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors. Leggett JD, Aspley S, Beckett SRG, DAntona AM, Kendall DA, Kendall DA, Br J Pharmacol 2004 141 253 262 10.1038/sj.bjp.0705607 14707029 (Pubitemid 38250895)
14. The mechanisms of action of PPARs. Berger J, Moller DE, Annu Rev Med 2002 53 409 435 10.1146/annurev.med.53.082901.104018 11818483 (Pubitemid 34177889)
15. International Union of Pharmacology. LXI. Peroxisome proliferator- activated receptors. Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, ORahilly S, et al. Pharmacol Rev 2006 58 726 741 10.1124/pr.58.4.5 17132851 (Pubitemid 44833742)
16. Guide to Receptors and Channels (GRAC), 5th Edition. Alexander SPH, Mathie A, Peters JA, Br J Pharmacol 2011 164 1 S324 22040146
17. Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. OSullivan SE, Br J Pharmacol 2007 152 576 582 17704824
18. International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pertwee RG, Howlett AC, Abood ME, Alexander SPH, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, et al. Pharmacol Rev 2010 62 588 631 10.1124/pr.110.003004 21079038
19. Novel time-dependent vascular actions of 9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor g. OSullivan SE, Tarling EJ, Bennett AJ, Kendall DA, Randall MD, Biochem Biophys Res Commun 2005 337 824 831 10.1016/j.bbrc.2005.09.121 16213464 (Pubitemid 41446988)
20. Time-dependent vascular actions of cannabidiol in the rat aorta. OSullivan SE, Sun Y, Bennett AJ, Randall MD, Kendall DA, Eur J Pharmacol 2009 612 61 68 10.1016/j.ejphar.2009.03.010 19285060
21. Docosahexaenoic acid suppresses the activity of peroxisome proliferator-activated receptors in a colon tumor cell line. Lee JY, Hwang DH, Biochem Biophys Res Commun 2002 298 667 674 10.1016/S0006-291X(02)02530-5 12419306 (Pubitemid 35356792)
22. Anandamide induced PPAR transcriptional activation and 3T3-L1 preadipocyte differentiation. Bouaboula M, Hilairet S, Marchand J, Fajas L, Le Fur G, Casellas P, Eur J Pharmacol 2005 517 174 181 10.1016/j.ejphar.2005.05.032 15987634 (Pubitemid 40977892)
23. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR- Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodriguez De Fonseca F, Rosengarth A, Luecke H, Di Giacomo B, Tarzia G, et al. Nature 2003 425 90 93 10.1038/nature01921 12955147 (Pubitemid 37101723)
24. Peroxisome proliferator-activated receptors- modulate dopamine cell activity through nicotinic receptors. Melis M, Carta S, Fattore L, Tolu S, Yasar S, Goldberg SR, Fratta W, Maskos U, Pistis M, Biol Psychiatry 2010 68 256 264 10.1016/j.biopsych.2010.04.016 20570248
25. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. Melis M, Pillolla G, Luchicchi A, Muntoni AL, Yasar S, Goldberg SR, Pistis M, J Neurosci 2008 28 13985 13994 10.1523/JNEUROSCI.3221-08.2008 19091987
26. The nuclear receptor peroxisome proliferator-activated receptor- mediates the antiinflammatory actions of palmitoylethanolamide. Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, Piomelli D, Mol Pharmacol 2005 67 15 19 10.1124/mol.104.006353 15465922 (Pubitemid 40069962)
27. Cannabinoid activation of PPAR: a novel neuroprotective mechanism. Sun Y, Alexander SPH, Garle MJ, Gibson CL, Hewitt K, Murphy SP, Kendall DA, Bennett AJ, Br J Pharmacol 2007 152 734 743 10.1038/sj.bjp.0707478 17906680 (Pubitemid 350034991)